SPONSOR
Guangzhou FineImmune Biotechnology Co., LTD.
Total Trials
2
Recruiting
2
Phases
Phase 1
Conditions studied: Solid TumorAdvanced Hepatocellular Carcinoma (HCC)GPC3 Positive Hepatocellular Carcinoma
NCT03891706 Phase 1
Recruiting
Individualized Tumor Specific TCR- T Cells in the Treatment of Advanced Solid Tumors
Solid Tumor
NCT07493044 Phase 1
Recruiting
An Open-Label, Phase I Clinical Trial of Super CAR-T With GPC3-Positive Advanced Hepatocellular Carcinoma
Advanced Hepatocellular Carcinoma (HCC)